| Date Filed | Type | Description |
| 05/01/2023 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Paid exercise price by delivering 346 shares
@ $450.79, valued at
$156k
Exercised 1,000 restricted stock units
@ $0 |
|
| 09/07/2022 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Paid exercise price by delivering 448 shares
@ $478.32, valued at
$214.3k
Exercised 902 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Paid exercise price by delivering 314 shares
@ $486.25, valued at
$152.7k
Granted 3,469 restricted stock units
@ $0
Exercised 633 restricted stock units
@ $0 |
|
| 08/19/2022 |
4
| Last Andrew J. (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 20,000 shares
@ $0.87, valued at
$17.4k
|
|
| 08/17/2022 |
4
| Last Andrew J. (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 10,000 shares
@ $0
Granted 45,000 options to buy
@ $0.97, valued at
$43.7k
|
|
| 07/19/2022 |
4
| Last Andrew J. (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Exercised 10,000 restricted stock units
@ $0 |
|
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Last Andrew J. (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 16,184 shares
@ $0 |
|
| 09/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2020 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Paid exercise price by delivering 346 shares
@ $436.27, valued at
$150.9k
Exercised 1,000 restricted stock units
@ $0 |
|
| 07/19/2019 |
4
| Last Andrew J. (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 45,000 options to buy
@ $2.12, valued at
$95.4k
|
|
| 04/30/2019 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Granted 5,000 restricted stock units
@ $0
Granted 5,000 options to buy
@ $299.24, valued at
$1.5M
|
|
| 04/24/2019 |
3
| Last Andrew J. (EVP, COO) has filed a Form 3 on BIO-RAD LABORATORIES, INC. |
| 09/04/2018 |
4
| Last Andrew J. (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 45,000 options to buy
@ $2.4, valued at
$108k
|
|
| 07/31/2018 |
4
| Last Andrew J. (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Bought 6,993 shares
@ $0
Bought 6,993 warrants
@ $3, valued at
$21k
|
|
| 11/15/2017 |
4
| Last Andrew J. (COO) has filed a Form 4 on INTREXON CORP|
Txns:
| Bought 2,000 shares
@ $12.1, valued at
$24.2k
|
|
| 08/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2017 |
4
| Last Andrew J. (Director) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 6,520 options to buy
@ $5.1, valued at
$33.3k
Granted 20,000 options to buy
@ $5.1, valued at
$102k
|
|
| 08/31/2016 |
4
| Last Andrew J. (COO) has filed a Form 4 on INTREXON CORP|
Txns:
| Granted 600,000 options to buy
@ $25.47, valued at
$15.3M
|
|
| 08/31/2016 |
3
| Last Andrew J. (COO) has filed a Form 3 on INTREXON CORP |
| 04/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/18/2016 |
4
| Last Andrew J. (Director) has filed a Form 4 on OncoCyte Corp |
| 02/17/2016 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Paid exercise price by delivering 7,466 shares
@ $14.09, valued at
$105.2k
Paid exercise price by delivering 2,182 shares
@ $14.09, valued at
$30.7k
Paid exercise price by delivering 2,819 shares
@ $14.09, valued at
$39.7k
|
|
| 02/10/2016 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Granted 37,297 shares
@ $0 |
|
| 02/19/2013 |
4
| Last Andrew J. (EVP and GM, GABU) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Granted 30,000 shares
@ $0
Paid exercise price by delivering 1,097 shares
@ $3.85, valued at
$4.2k
Granted 50,000 options to buy
@ $3.84, valued at
$192k
|
|
| 12/18/2012 |
4
| Last Andrew J. (EVP and GM, GABU) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Paid exercise price by delivering 1,835 shares
@ $3.32, valued at
$6.1k
|
|
| 08/21/2012 |
4
| Last Andrew J. (EVP and GM, GABU) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Paid exercise price by delivering 1,376 shares
@ $3.86, valued at
$5.3k
|
|
| 08/06/2012 |
4
| Last Andrew J. (EVP and GM, GABU) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Bought 10,000 shares
@ $4.06, valued at
$40.6k
|
|
| 02/22/2012 |
4
| Last Andrew J. (Chief Commercial Officer) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Paid exercise price by delivering 1,048 shares
@ $4.61, valued at
$4.8k
|
|
|